loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2125382 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Purdue Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HYDROMORPHONE HYDROCHLORIDE (1)

    filter

    01 PURDUE PHARMA (1)

    filter

    01 CAPSULE (SUSTAINED-RELEASE) (1)

    filter

    01 24MG (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hydromorphone Hydrochloride

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE (SUSTAINED-REL...
    24MG
    HYDROMORPH CONTIN-CONT...
    Canada
    2125382
    50
    Narcotic (CDSA I)
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 2125382

    Looking for CTD TGA MCC DOSSIER APPLICATION 2125382 1

    19

    Purdue Pharma, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is HYDROMORPHONE HYDROCHLORIDE, with a corresponding application number 2125382 and regulatory information .

    proudly manufactured in the

    Purdue Pharma's HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG CAPSULE (SUSTAINED-RELEASE), medication with 24MG of HYDROMORPHONE HYDROCHLORIDE.

    Post Enquiry
    POST ENQUIRY